Some of the world’s largest pharmaceutical companies are offering “best practice” advice on how to create a greater return on investment in data warehousing. In a new report from Best Practice LLC, the companies – 3M Pharmaceuticals, Bayer Pharmaceuticals, Bausch & Lomb, Bergen Brunswig, Columbia HCA, Eli Lilly, GlaxoSmithKline, Aventis, Johnson & Johnson, NDC, Pharmacia, Scott Levin and SmithKline Beecham – note that achieving better ROI begins with senior executive involvement. “In the past, benchmark partners have had to battle departmental leaders who resisted making their operational information accessible throughout the organization because information access was registered as a form of power and control,” the report says. “Senior executives can be instrumental in demonstrating the company’s dedication to the data warehousing effort and in heralding system benefits.” The pharmaceutical companies cited these priorities for building a better ROI on data warehousing:

  1. Shift corporate culture to rely on the data warehouse
  2. Align planning with corporate strategy
  3. Provide adequate resources to maintain and expand
  4. Demonstrate ROI
  5. Build executive support
  6. Maintain complete and updated content
  7. Employ correct technology and upgrade
  8. Plan sufficient training

“High-level support tended to streamline resource allocation, accelerate improvement cycles and increase general usage of the data warehouse,” the report says.

Register or login for access to this item and much more

All Information Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access